Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.
- DOI
- 10.1016/j.ebiom.2026.106477
- Published
- 2026 Sep 11
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2026.106477,
title = {Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.},
author = {Undurraga M and Lang N and Koessler T and Diciolla A and Di Marco M and Mach N and Raimond C and Genoud V and Du Bois V and Tille JC and Bornand A and Moore JS and Weiner M and Smekens L and Sandoval JL and Terzic J and Christinat Y and Veillard J and Tsantoulis P and Thoueille P and Mercier T and Monig S and Petignat P and Toso C and Decosterd L and Hübner M and Labidi-Galy I and Ris F},
year = {2026},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2026.106477},
url = {https://doi.org/10.1016/j.ebiom.2026.106477}
}RIS
TY - JOUR TI - Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study. AU - Undurraga M AU - Lang N AU - Koessler T AU - Diciolla A AU - Di Marco M AU - Mach N AU - Raimond C AU - Genoud V AU - Du Bois V AU - Tille JC AU - Bornand A AU - Moore JS AU - Weiner M AU - Smekens L AU - Sandoval JL AU - Terzic J AU - Christinat Y AU - Veillard J AU - Tsantoulis P AU - Thoueille P AU - Mercier T AU - Monig S AU - Petignat P AU - Toso C AU - Decosterd L AU - Hübner M AU - Labidi-Galy I AU - Ris F PY - 2026 JO - EBioMedicine DO - 10.1016/j.ebiom.2026.106477 UR - https://doi.org/10.1016/j.ebiom.2026.106477 ER -
APA
M, U., N, L., T, K., A, D., M, D. M., N, M., C, R., V, G., V, D. B., JC, T., A, B., JS, M., M, W., L, S., JL, S., J, T., Y, C., J, V., P, T., P, T., T, M., S, M., P, P., C, T., L, D., M, H., I, L., & F, R. (2026). Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106477
Source records
- pubmed · retrieved 2026-09-26T19:15:18.305Z